Xiaohong Du

541 total citations
19 papers, 374 citations indexed

About

Xiaohong Du is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xiaohong Du has authored 19 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Xiaohong Du's work include Cancer, Hypoxia, and Metabolism (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Cancer-related molecular mechanisms research (3 papers). Xiaohong Du is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Cancer-related molecular mechanisms research (3 papers). Xiaohong Du collaborates with scholars based in China, United States and France. Xiaohong Du's co-authors include Junfeng Ye, Wengang Chai, Juping Wang, Feng Ding, Xiaoming Lin, Jinliang Xing, Qiang Zhou, Ping Zhang, Heyu Huang and Peng Yuan and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Cancer Letters.

In The Last Decade

Xiaohong Du

19 papers receiving 372 citations

Peers

Xiaohong Du
Jun-sheng Ni China
Yunyun Xiao China
Lexiang Zeng China
Yuansheng Duan China
Huohui Ou China
Xueqiang Ding China
Sampa Ghose India
Jiangbo Ren China
Jun-sheng Ni China
Xiaohong Du
Citations per year, relative to Xiaohong Du Xiaohong Du (= 1×) peers Jun-sheng Ni

Countries citing papers authored by Xiaohong Du

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Du more than expected).

Fields of papers citing papers by Xiaohong Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Du. The network helps show where Xiaohong Du may publish in the future.

Co-authorship network of co-authors of Xiaohong Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Du. A scholar is included among the top collaborators of Xiaohong Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Du. Xiaohong Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Hua, et al.. (2021). High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia. Aging. 13(8). 11988–12006. 10 indexed citations
2.
Ye, Junfeng, et al.. (2019). Mining featured biomarkers associated with vascular invasion in HCC by bioinformatics analysis with TCGA RNA sequencing data. Biomedicine & Pharmacotherapy. 118. 109274–109274. 28 indexed citations
3.
Li, Jibin, Ning Liang, Xiaoyu Long, et al.. (2019). SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS/NFκB signaling. Cancer Letters. 461. 44–55. 51 indexed citations
4.
Ye, Junfeng, et al.. (2019). Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p. OncoTargets and Therapy. Volume 12. 415–422. 40 indexed citations
5.
Lu, Ying, Xuhui Liu, Xiaohong Du, et al.. (2019). [Ikaros family zinc finger 1 mutation is a poor prognostic factor for adult Philadelphia chromosome positive acute lymphoblastic leukemia].. PubMed. 58(4). 301–306. 2 indexed citations
6.
Zhou, Peng, Juping Wang, Xiaohong Du, et al.. (2018). Nanoparticles in Biomedicine-Focus on Imaging Applications. Engineered Science. 11 indexed citations
7.
8.
Su, Chang, Yan He, Wei Li, et al.. (2018). Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma. PLoS ONE. 13(6). e0198896–e0198896. 19 indexed citations
9.
Du, Xiaohong, et al.. (2018). Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies. Current Pharmaceutical Design. 23(39). 5997–6010. 60 indexed citations
10.
Li, Xin, Xu Guo, Deyang Li, et al.. (2018). Multi‐regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer. International Journal of Cancer. 143(5). 1143–1152. 22 indexed citations
11.
Chen, Cheng, Yanna Ba, Deyang Li, et al.. (2017). Genetic variations of mitochondrial genome modify risk and prognosis of hepatocellular carcinoma patients. Clinics and Research in Hepatology and Gastroenterology. 41(4). 378–385. 15 indexed citations
12.
Jin, Shuo, Xiaoju Shi, Siyuan Wang, et al.. (2017). Drainage fluid and serum amylase levels accurately predict development of postoperative pancreatic fistula. World Journal of Gastroenterology. 23(34). 6357–6357. 23 indexed citations
13.
Zhang, Jing, Xingchun Zhou, Hulin Chang, et al.. (2016). Hsp60 exerts a tumor suppressor function by inducing cell differentiation and inhibiting invasion in hepatocellular carcinoma. Oncotarget. 7(42). 68976–68989. 32 indexed citations
14.
Jin, Shuo, Xiaoju Shi, Xiaodong Sun, et al.. (2015). The Gastric/Pancreatic Amylase Ratio Predicts Postoperative Pancreatic Fistula With High Sensitivity and Specificity. Medicine. 94(3). e339–e339. 8 indexed citations
15.
Du, Xiaohong, Shaogui Wan, Yibing Chen, et al.. (2014). Genetic Variants in Genes of Tricarboxylic Acid Cycle Key Enzymes Predict Postsurgical Overall Survival of Patients with Hepatocellular Carcinoma. Annals of Surgical Oncology. 21(13). 4300–4307. 5 indexed citations
16.
Du, Xiaohong, et al.. (2012). Zn2+-SCMC Versus HA for Preventing Intraperitoneal Adhesions: A Rat Model Study. International Journal of Medical Sciences. 9(6). 467–471. 6 indexed citations
17.
Liu, Xuhui, Xiaohong Du, Dong Chen, et al.. (2012). Long term curative effects of sequential therapy with all-trans retinoic acid, arsenious oxide and chemotherapy on patients with acute promyelocytic leukemia. Hematology. 17(6). 311–316. 12 indexed citations
18.
Chen, Chan, Zhiyi Wang, Liangxing Wang, Xiaohong Du, & Xiaowei Zhao. (2011). [Effects of puerarin on proliferation, apoptosis and Kv1.5 gene expression of pulmonary artery smooth muscle cells induced by hypoxia].. PubMed. 29(10). 731–4. 3 indexed citations
19.
Zhang, Ping, Xiaohong Du, Zhipeng Sun, & Lijun Xu. (2009). Expression of Redox Factor-1 in Early Injury Period After Liver Transplantation in Rat Model. Cellular and Molecular Immunology. 6(4). 309–313. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun-sheng Ni Breakdown of academic impact, for papers by Yunyun Xiao Breakdown of academic impact, for papers by Lexiang Zeng Breakdown of academic impact, for papers by Yuansheng Duan Breakdown of academic impact, for papers by Huohui Ou Breakdown of academic impact, for papers by Xueqiang Ding Breakdown of academic impact, for papers by Sampa Ghose Breakdown of academic impact, for papers by Jiangbo Ren
Rankless by CCL
2026